NCT07453524 Assessing Chronic Pain Patient Preferences
| NCT ID | NCT07453524 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Université Catholique de Louvain |
| Condition | Chronic Pain |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2026-03-15 |
| Primary Completion | 2027-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2026-03-15 with a primary completion date of 2027-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this study is to ask chronic pain patients their preferences regarding which side effects of pain medications are least acceptable in relation to their pain relief benefits. This information may help in the selection of improved treatment options in the future.
Eligibility Criteria
Inclusion Criteria: * Aged over 18 years. * Being treated with pain medication. * (Chronic-)Pain for at least 3 months. * Capacity to understand and provide an informed consent form. Exclusion Criteria: * Insufficient French or English language skills. * Epilepsy treated by an anti-epileptic. * Alzheimer's disease. * Parkinson's disease
Frequently Asked Questions
Who can join the NCT07453524 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Chronic Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07453524 currently recruiting?
Yes, NCT07453524 is actively recruiting participants. Visit ClinicalTrials.gov or contact Université Catholique de Louvain to inquire about joining.
Where is the NCT07453524 trial being conducted?
This trial is being conducted at Brussels, Belgium.
Who is sponsoring the NCT07453524 clinical trial?
NCT07453524 is sponsored by Université Catholique de Louvain. The trial plans to enroll 200 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.